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(5.1%2.7%) compared with control group (6.7%3.2%) (P <0.01 VS P¼0.04) at 10
mins after tiroﬁban infusion. The PMPs were also lower in intracoronary group than
intravenous group (P¼0.02). At 24 hours after tiroﬁban infusion, the PMPs of
intracoronary and intravenous group was similar (P>0.05) and was signiﬁcantly
higher than control group (P¼0.01 VS P ¼0.03) .PMPs was similar at 12 after
stopping tiroﬁban use among the 3 groups (P>0.05) .Intracoronary group were su-
perior to intravenous group and control group in terms of TIMI ﬂow grade (P¼0.03
VS P<0.01) and TIMI myocardial perfusion grade (P¼0.02 VS P<0.01) immediately
after PCI. MACEs rate in intracoronary group was lower than control group (P¼0.03) .And
MACEs rate between intracoronary group and intravenous group, intravenous group
and control group were similar (P>0.05, respectivly). The incidence of bleeding
events among 3 groups was similar.
Conclusions: Intracoronary tiroﬁban compared to the intravenous group, can effec-
tively reduce the number of PMPs in patients with acute ST-segment elevation
myocardial infarction undergoing emergency interventional treatment, achieve the
purpose of the inhibition of activated platelets quickly, and reduce total MACEs
events rate, but did not increase the risk of bleeding.
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TNF receptor-associated factor 6 (TRAF6) mediates the angiotensin-induced
non-canonical TGFb pathway activation and differentiation of c-kit+ cardiac
stem cells
Cao Qing, Shuyan Chen
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Objectives: TNF receptor-associated factor 6 (TRAF6) acts as a multifunctional
regulator of the transforming growth factor (TGF) -b signaling pathway, and mediates
Smad-independent JNK and p38 activation via TGF-b. This study was performed to
test the hypothesis that TGF-b/TRAF6 is essential for angiotensin-II (Ang II) -induced
differentiation of rat c-kit+ cardiac stem cells (CSCs) .
Methods: c-kit+ CSCs were isolated from neonatal Sprague Dawley (SD) rats, and
their c-kit status was conﬁrmed with immunoﬂuorescence staining. A TGF-b type I
receptor inhibitor (SB431542) or the small interfering RNA (siRNA) -mediated
knockdown of TRAF6 were used to investigate the role of TRAF6 in TGF-b
signaling. Rescue of TRAF6 siRNA transfected cells with a 3’UTR deleted siRNA
insensitive construct was conducted to rule out the off target effects of the siRNA.
TRAF6 dominant negative (TRAF6DN) vector was constructed and used to infect c-
kit+ CSCs, and western blotting was used to assess the expression of TRAF6, JNK,
p38, cardiac-speciﬁc proteins, and Wnt signaling proteins. Physical interactions be-
tween TRAF6 and TGFb receptors were studied by coimmunoprecipitation.
Results: Cardiac differentiation was suppressed in the absence of TRAF6. Forced
expression of TRAF6 enhanced the expression of TGF-b-activated kinase1 (TAK1),
and inhibited Wnt signaling. Furthermore, TRAF6 increased the expression of car-
diac-speciﬁc proteins (cTnT and Cx-43) but inhibited the expression of Wnt3a.
Conclusions: Our data suggest that TRAF6 plays an important role in Ang II induced
differentiation of c-kit+ CSCs via the non-canonical signaling pathway.
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Objectives: Herbal medicine, also known as Chinese medicine, plays a role in
treatment of heart failure. Aconite, as one of Chinese medicine, is useful for treatment
of heart failure. purpose of this study is to test efﬁcacy of aconite compound in
improving heart funciton from both clinical and animal study to provide reference for
clinical application.
Methods: (1) Clinical study 41 Patients with chronic heart failure (CHF) were given
treatment of Chinese medicine aconite compound (twice daily for 8 weeks). Before
and after treatment, cardiac function (according to New York Heart Association
NYHA classiﬁcation method) and echocardiography (LVEF%) were observed; (2)
Animal study SD rats (SPF, male, 240 - 280g), acute heart failure model was used as
follows (isolated right carotid artery, heparin catheter was inserted through aortic
valve into left ventricular cavity, intravenous injection of nimodipine (0.6 mg/kg),
when left ventricular pressure maximal rate of rise (+LVdp/dtmax) decreased signif-
icantly, given treatment drugs, (Aconite compound dose as 7g/kg and duodenal
administration, and Cedilanid 0.2mg/kg, femoral vein injection), continue tracings 1h,
including before modeling, modeling immediately, after administration 10 mins, 20
mins, 30 mins, 40 mins, 50 mins, 60 mins to observe following indicators: left ven-
tricular systolic pressure (LVSP mmHg), left ventricular end-diastolic pressure
(LVEDP mmHg) .
Results: (1) 21 patients were male (44.9%), 20 patients were female (55.1%), mini-
mum age is 53 years, the maximum age is 95 years, mean age 73.88 +1.343 (years old),
P¼0.24>0.05, normal distribution; there was improvement of heart function acording
to before and after treatment echocardiography, the LVEF% Value was as follows:
44.71 +14.846 % VS 52.05 +14.854 %, t¼-2.669, P¼0.014<0.05; (2) Compared with
normal group, LVEDP (-0.290.57 vs 1.960.99, P<0.05) were signiﬁcantly higher,
LVSP (105.376.39 VS 129.007.47, P <0.01) was signiﬁcantly lower for acuteC58 JACC Vol 64/16/Suppl C j Octobheart failure group. After femoral vein injection cedilanid 0.2mg/kg, compared with
the model group, LVEDP decreased signiﬁcantly (-0.741.12 VS -0.531.18), LVSP
signiﬁcantly higher (107.737.49 VS 117.117.16 ) after the treatment at 10mins,
118.007.45 at 20 mins, 118.647.44 at 30mins, 120.058.25 at 40mins,
122.748.80 at 50 mins, 125.049.71 at 60mins), heart failure model copied suc-
cessfully; Aconite compound 7g/kg were administered orally to acute heart failure
rats, LVSP (105.376.39 in model group vs 112.365.83 at 10 mins, 115.696.29 at
20mins, 117.217.71 at 30mins, 118.3410.99at 40mins, 120.08 12.82 at 50mins,
123.9611.95 at 60mins), LVEDP (1.960.99 VS 0.050.87 at 10mins, -0.00 0.99
at 20 mins, -0.06 0.85 at 30mins, 0.02 0.84 at 40mins, 0.140.87at 50mins,
0.130.77 at 60 mins after the treatment) showed signiﬁcant improvement
(P<0.05;P<0.01).
Conclusions: Aconite compound can be used for the heart failure by improving hear
function, and there is no signiﬁcant side effects if it is used properly.
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Objectives: Currently, cardiosphere (CSP) and cardiosphere-derived cells (CDCs) are
mainly obtained through myocardial biopsy and surgical, but there is limited access to
tissue size, technical requirements and faced with infection, trauma and other prob-
lems. We assume that there is still a large number cardiac stem cell survival in the
cadaver cardiac, we can get a sufﬁcient amount of functional CSPs and CDCs through
cadaver autopsy methods.
Methods: Mouse (C57BL/6) were sacriﬁced and placed in a refrigerator at 4 C for
0 to 3 days, cardiac tissue was removed at different time points (D0, D1, D2, D3), cut
into small pieces (approximately 1.5 cm3) and placed into dishes to culture explant-
derived cells (EDCs) with complete explant medium. Flow cytometry analysis the
expression of stem cell surface markers of EDCs such as CD117, CD133, CD105,
Sca-1, CD90. EDCs were cultured with Cardiosphere growth medium to form CSP.
CD105, CD117, GATA-4, Nkx2.5 and Connexin-43 were detected by immunoﬂuo-
rescence. CSP was placed in ﬁbronectin covered ﬂasks and grow into a layer of CDCs.
Early cardiac transcription factors GATA-4, Nkx2.5 and Connexin-43 were detected
by polymerase chain reaction (PCR), cardiac stem cell surface markers CD117 and
Sca-1 were tested by ﬂow cytometry. The proliferation ability was tested by cck-8, c-
TnI and vWF were stained by immunoﬂuorescence after induction of differentiation.
Results: Nine days after placing the cardiac tissue in dishes, EDCs from mouse
cadaver cardiac were successfully isolated and cultured. Each group of EDCs are rich
in stem cell surface markers expressing such as CD117, CD133, CD105, Sca-1,
CD90, and could culture into CSP and CDCs. With the extension of the dead days, the
number of EDCs was able to harvest from the autopsy gradually decreased, the
amount of EDCs could harvest at D3 decreased signiﬁcantly (the number of each 60
mm dishes at D0, D1, D2, D3 were 86.005.27104, 66.923.15104,
49.673.17104, 23.751.52104, respectively). There is no signiﬁcant differences
in CD117 and Sca-1 expression at D0 and D1 in EDCs and CDCs, but decreased at D2
and D3. No signiﬁcant difference was found in the ability of EDCs to form CSPs (the
number of each well of 24-well plate at D0, D1, D2, D3 were 38.331.25,
38.002.45, 37.331.25, 38.002.16, respectively), and each group of CSPs was
positive expression CD117, CD105, GATA-4, NKX2.5 and Connexin-43. CDCs
obtained from cadaver autopsy both express GATA-4, Nkx2.5 and Connexin-43 when
detected by PCR and immunoﬂuorescence, but decreased in D2 and D3. There is no
signiﬁcant difference in proliferation when detect by cck-8 and c-TnI, vWF expression
after induction of CDCs.
Conclusions: There is a variety of stem cells survival in cadaveric cardiac even at three
days post-mortem. EDCs harvested through cadaver autopsy methods can form enough
CSPs and CDCs. CDCs from cadaver autopsy also have strong ability of proliferation
and differentiation. CSPs and CDCs obtained from cadaver autopsy may be used as a
source or alternative sources of allograft transplantation and needs further research in
vivo, which may solve the insufﬁcient source problems existing in cardiac stem cells.
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Statin effects on UA patients microRNA expression proﬁle and regulatory
functional network analysis
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Objectives: Unstable angina (UA), an acute coronary syndrome caused by disruption
of atherosclerotic plaque triggered thrombosis. The blood vessel narrow and reduction
of blood ﬂow induce the symptom. Statin therapy beneﬁts UA patients by cholesterol
independent effect. Yet the mechanism of statin pleiotropic effect remained to be
study. MicroRNAs (miRNAs), small non-coding RNAs, are post-transcriptional
regulators of gene expression. In this study we aim to investigate statins’ novel
mechanism mediated by miRNAs. Moreover we carry out systematic analysis of the
miRNAs functional networks in atherosclerotic lesions.er 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
Methods: UA patients who treated with statin (n¼6) and without statin (n¼6) whole
blood sample were detected miRNAs proﬁle by using MiRNAs taqman low density
array. 17 signiﬁcant differential upregulated miRNAs were signiﬁcant. MiRNAs tar-
gets were predicted by three bioinformatic tools. Putitive targets were clustered into
different pathway and cell types by DAVID functional tool. GEO database Stable
(n¼6) vs rupture plaque macrophage (n¼5); Early (n¼13) vs Advance carotid
atherosclerotic plaque (n¼16) provided information were calculated by sam to ﬁgure
out pathway in the rupture plaque. By using cytoscape to visualize the miRNAs
regulated functional network.
Results: From the miRNA array data, 17 differential expressed miRNAs in the statin
group compare without statin group in the UA patients.
MiRNAs cells type target pathway network appears that its targets in a. plaque
macrophage enriched in pathway of hemostasis, signaling in NGF, opioid signaling;
b. Platelet in pathway of hemostasis, signaling by Rho GTPases, signaling by NGF,
integrin cell surface interactions, signaling by insulin receptor, signaling by EGFR;
c. Monocyte in pathway of Signaling by NGF, Apoptosis, hemostasis, signaling by
PDGF, Axon guidance, signaling by Notch; d. Endothelial cell. Signaling by NGF,
Apoptosis signaling by Rho GTPases, membrane trafﬁcking etc. MiRNAs targeted
resident macrophage of rupture plaque are major in signaling for NGF, signaling by
Rho GTPases and hemostasis. The NGF signaling pathway, hemostasis and Rho
GTPase signaling also emerged in the carotid plaque. After combine the two miRNA
target networks, only the hemostasis, Rho GTPase singling pathway and signaling in
immune system had been targeted.
Conclusions: Our bioinformatic analysis on UA patients’ miRNAs proﬁles suggested
MiRNAs functioning in the plaque macrophage and platelet miRNA targets are major
enrich in hemostasis, while in monocyte NGF apoptosis and Rho GTPase and in
endothelial cell. Further integrate data miRNAs and mRNA in atherosclerotic lesion
indicate that statin induced miRNAs target signaling pathway of Rho GTPase,
Hemostasis in plaque and additional signaling in immune system was targeted by
miRNAs in vulnerable plaque.
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Objectives: It has been previously demonstrated that hypoxia preconditioning (HP)
potentiated the therapeutic effect of mesenchymal progenitor cells (MPC) on
myocardial infarction. Given that exosomes, released from various cells, have been
well recognized to play critical roles in cell-to-cell communication, we documented
the exosomal miRNAs secreted from MPC with HP and examined their roles in
cardiac function preservation after myocardial injury.
Methods: For HP, MPC was subjected to repeated cycles of hypoxia (30 min) with
intermittent reoxygenation (10 min) for three cycles. In vitro, CM was incubated in
hypoxia for 24 hours to establish injury model. Concentrated conditioned medium
(CdM) of MPC was extracted to be applied in the subsequent experiments, and
exosome was isolated from CdM by differential centrifugation. GW4869, a special
inhibitor to exosome, was used to interdict exosome release. The miRNAs tran-
scriptome in exsome was analyzed by microarray and veriﬁed by quantiﬁed-PCR.
Alternatively, ago-miR-210 or antago-miR-210 transfection was performed to up- or
down-regulate intracellular miR-210 in MPC, respectively. In vivo, rats were sub-
jected to left anterior descending (LAD) ligation followed by injection of either CdM-
MPCcontrol, CdM-MPCHP, CdM-MPCHP-GW4869, or exo-MPCHP into the peri-infarct
region, which were followed up for 4 weeks.
Results: It was demonstrated that CdM-MPCHP exerted potent beneﬁcial effect on the
survival of CM in hypoxia, as indicated in a remarkable decrease in apoptosis rate of
CM treated with CdM-MPCHP compared to that of with CdM-MPCcontrol
[(12.32.61) % vs. (28.73.73) %, P<0.05] in TUNEL assay; however, there was an
obvious raise in CM apoptosis between CdM-MPCHP-GW4869 group and CdM-
MPCHP one (P<0.05). Among 26 signiﬁcantly up- or down-regulated miRNAs in
exosome derived from CdM-MPCHP compared to that from CdM-MPCcontrol, miR-
210, a survival-associated miRNA, was further investigated. It was suggested that
miR-210 in CdM-MPCHP was signiﬁcantly decreased following CM cultured in this
medium (P<0.05); meanwhile, the expression of miR-210 in CM cultured with CdM-
MPCHP was statistically increased by 2.76 fold compared to the control. After over-
expression of miR-210 in MPC, exosome was isolated from CdM-MPCmiR-210, and
added into CM medium. The co-location detection with an immunoﬂuorescence in
miR-210 and two special markers of exosome, CD81 and CD63, was performed to
verify that miR-210 was secreted through exosome release. Afterwards, it was
observed that miR-210 was internalized by CM via exosome-intake, resulting in a
prominent rise in CM survival in a similar manner to CdM-MPCHP incubation.
Intriguingly, miR-210 knock-down in MPC remarkably abolished the cardioprotection
of both CdM-MPCHP and exo-MPCHP. In vivo, a dramatically favorable effect, either
of CdM-MPCHP or of exo-MPCHP, was discovered on cardiac remodeling after
myocardial infarction compared with that of CdM-MPCcontrol, with a remarkable
enhancement of left ventricular ejection function (LVEF) by 1.31 fold or by 1.27 fold
respectively; however, there was not statistical difference in LVEF could be indicated
between CdM-MPCHP-GW4869 group and CdM-MPCcontrol one.
Conclusions: Our investigation evidenced that exosome-mediated transfer of miR-
210 from MPC to CM facilitated the myocardial survival in hypoxia, providing a
novel insight into the mechanism of cell-based treatment for cardiovascular diseases.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BGW25-e5168
Impaired Post-Transcriptional Regulation of RyR2 by microRNA-106b-25
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Objectives: Atrial ﬁbrillation (AF) is the most common sustained arrhythmia yet
current pharmacological treatments are only moderately effective. Enhanced sarco-
plasmic reticulum (SR) Ca2+ leak via ryanodine receptor type-2 (RyR2) contributes to
AF pathogenesis and preliminary data in atrial samples from paroxysmal AF (pAF)
patients showed an upregulation of RyR2 proteins with no change in mRNA levels.
This suggests that post-transcriptional regulation of RYR2 by microRNAs (miRNAs)
may play a role in RyR2 dysregulation in pAF. Since bioinformatic analysis suggests
that miR-106b and miR-93, members of the miR-106b-25 cluster, could target RYR2-
3’UTR, we hypothesized that loss of the miR-106b-25 cluster may promote AF via
enhanced RyR2-mediated SR Ca2+ leak.
Methods: RYR2-3’UTR luciferase reporter assay was performed in HEK293 cells.
Telemetry ECG recordings, intracardiac electrophysiology (EP) studies, Ca2+ imaging
and immunocytochemistry (ICC) using isolated atrial myocytes, and Western blotting
(WB) were performed in miR-106b-25 homozygous knockout (miR-106b-25 -/-) mice
and wildtype (WT) littermates. Levels of mRNAs and mature miRNAs were measured
using quantitative real-time (qRT) -PCR in both mice and atrial samples from pAF
patients.
Results: Luciferase reporter assay conﬁrmed that miR-93 targets RYR2-3’UTR. WB
and qRT-PCR revealed an upregulation of RyR2 proteins in miR-106b-25 -/- atria
(n¼7) by 42% (P<0.01 vs. WT, n¼4) but unchanged mRNA levels. ICC showed that
the subcellular localization of RyR2 remained unchanged in miR-106b-25 -/- atrial
myocytes. Ca2+ spark frequency (CaSF) normalized to SR load and total SR Ca2+ leak
were doubled in miR-106b-25 -/- atrial cells (both P<0.05 vs. WT; 3 animals/group).
These increases in CaSF and SR Ca2+ leak were normalized to WT levels when miR-
106b-25 -/- atrial myocytes were incubated with the RyR2-blocker K201 (1 mmol/L;
both P<0.05 vs. untreated cells). Telemetry and EP studies showed that miR-106b-25
-/- mice exhibited more atrial ectopy (82 events/hr, n¼8) than WT mice (1.00.5
events/hr, n¼6, P<0.05) and were more susceptible to pacing-induced AF (75%,
n¼8) than WT mice (12.5%, n¼8, P<0.05). RyR2-blocker K201 (10mg/kg, i.p.)
reduced the incidence of pacing-induced AF in miR-106b-25 -/- mice (14.3%, n¼7,
P<0.05 vs miR-106b-25 -/-). Finally, qRT-PCR demonstrated that the miR-106b-25
cluster is downregulated in atrial samples from pAF patients compared with patients in
sinus rhythm (n¼5/group, P<0.05).
Conclusions: These results suggest that abnormal miR-106b-25 regulation of RYR2
expression is an important molecular mechanism involved in the proarrhythmic RyR2
dysregulation in pAF patients. miR-93 mimic may constitute a novel therapeutic
strategy for pAF patients associated with RyR2 hyperactivity
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Objectives: Atrial ﬁbrillation (AF) is the most common form of sustained cardiac
arrhythmia in humans and is responsible for substantial morbidity and mortality
worldwide. Emerging evidence indicates that abnormal cardiovascular development is
involved in the pathogenesis of AF.
Methods: In this study, the coding exons and splice sites of the NKX2-5 gene, which
encodes a homeodomain-containing transcription factor essential for cardiovascular
genesis, were sequenced in 146 unrelated patients with lone AF as well as the
available relatives of the mutation carriers. A total of 700 unrelated ethnically matched
healthy individuals used as controls were genotyped. The disease-causing potential of
the identiﬁed NKX2-5 variations was predicted by Mutation Taster and PolyPhen-2.
The functional characteristics of the mutant NKX2-5 proteins were analyzed using a
dual-luciferase reporter assay system.
Results: As a result, two heterozygous NKX2-5 mutations, including a previously re-
ported P.E21Q and a novel P.T180A mutation, were identiﬁed in two families with AF
transmitted in an autosomal dominant pattern. The mutations co-segregated with AF in
the families with complete penetrance. The detected substitutions, which altered the
amino acids highly conserved evolutionarily across species, were absent in 700 control
individuals and were both predicted to be causative. Functional analyses demonstratedasic and Translational Medicine C59
